Idexx Laboratories

IDXX Health Care Market cap $40.1B as of Sep 14, 2026 16:00 ET S&P 500

Q2 FY26 Apr 1 – Jun 30, 2026 reported Aug 4, 2026

Revenue$1.22B +10% year over year

Gross profit$0.78B 64% margin

Operating profit$0.43B 35% margin

Net profit$0.34B 28% margin

The numbers behind the diagram

All figures in billions of U.S. dollars, for Q2 FY26 (period ends Jun 30, 2026).
Item	Value	Share of revenue	Year over year
Revenue	1.22	100%	+10%
IDEXX VetLab consumables	0.43	35%	+15%
Reference laboratory	0.41	34%	+11%
Rapid assay products	0.10	8%	+1%
Recurring	0.08	6%	+11%
Other	0.06	5%
Water segment	0.06	5%	+15%
capital - instruments	0.05	4%	−19%
services & accessories	0.04	3%	+3%
Cost of revenue	−0.44	36%
Gross profit	0.78	64% margin	+1pp
R&D	−0.07	5%	+0pp
Sales & marketing	−0.17	14%	+0pp
G&A	−0.12	10%	+1pp
Operating profit	0.43	35% margin	+1pp
Interest & other costs	−0.01
Tax	−0.08
Net profit	0.34	28% margin	+1pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q1 FY26 (period ends Mar 31, 2026).
Item	Value	Share of revenue	Year over year
Revenue	1.14	100%	+14%
IDEXX VetLab consumables	0.41	36%	+20%
Reference laboratory	0.39	34%	+12%
Rapid assay products	0.09	7%	+1%
Recurring	0.07	7%	+12%
Other	0.05	5%
Water segment	0.05	4%	+11%
capital - instruments	0.04	4%	+33%
services & accessories	0.04	3%	+11%
Cost of revenue	−0.42	37%
Gross profit	0.72	63% margin	+1pp
R&D	−0.07	6%	+0pp
Sales & marketing	−0.18	15%	+0pp
G&A	−0.12	11%	+1pp
Operating profit	0.36	32% margin	+0pp
Interest & other costs	−0.01
Tax	−0.08
Net profit	0.28	24% margin	+0pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q4 FY25 (period ends Dec 31, 2025).
Item	Value	Share of revenue	Year over year
Revenue	1.09	100%	+14%
Veterinary software, services…	0.35	32%
Water segment revenue	0.20	18%
CAG Diagnostics capital…	0.20	18%	+52%
CAG Diagnostics services and…	0.14	13%	+5%
LPD segment revenue	0.13	12%
Systems and hardware	0.07	6%	+12%
Other	0.01	1%
Cost of revenue	−0.43	40%
Gross profit	0.66	60% margin	+1pp
R&D	−0.07	6%	+0pp
Sales & marketing	−0.17	15%	+0pp
G&A	−0.11	10%	−1pp
Operating profit	0.32	29% margin	+2pp
Interest & other costs	−0.01
Tax	−0.06
Net profit	0.25	23% margin	+0pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q3 FY25 (period ends Sep 30, 2025).
Item	Value	Share of revenue	Year over year
Revenue	1.11	100%	+13%
IDEXX VetLab consumables	0.39	35%	+18%
Reference laboratory	0.36	33%	+10%
Rapid assay products	0.09	8%	−4%
Recurring	0.07	6%	+10%
Other	0.06	5%
Water segment	0.05	5%
capital - instruments	0.05	5%	+74%
services & accessories	0.03	3%	+3%
Cost of revenue	−0.42	38%
Gross profit	0.68	62% margin	+1pp
R&D	−0.06	6%	+0pp
Sales & marketing	−0.16	14%	−1pp
G&A	−0.11	10%	+0pp
Operating profit	0.36	32% margin	+1pp
Interest & other costs	−0.01
Tax	−0.07
Net profit	0.28	25% margin	+1pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q2 FY25 (period ends Jun 30, 2025).
Item	Value	Share of revenue	Year over year
Revenue	1.11	100%	+11%
IDEXX VetLab consumables	0.38	34%	+15%
Reference laboratory	0.37	33%	+6%
Rapid assay products	0.10	9%	−3%
Recurring	0.07	6%	+9%
capital - instruments	0.06	5%	+66%
Other	0.05	5%
Water segment	0.05	5%
services & accessories	0.04	3%	+8%
Cost of revenue	−0.42	37%
Gross profit	0.70	63% margin	+1pp
R&D	−0.06	6%	+0pp
Sales & marketing	−0.16	14%	+0pp
G&A	−0.10	9%	−7pp
Operating profit	0.37	34% margin	+7pp
Interest & other costs	−0.01
Tax	−0.07
Net profit	0.29	26% margin	+6pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

Financial health

The balance sheet, the quarter's capital flow, the debt schedule and the capital structure of the quarter shown above.

Every set of results we hold, newest first. Open one on its own page.

Quarter	Period	Reported	Revenue	Year over year	Operating margin	Net profit	Net margin
Q2 FY26 Apr 1 – Jun 30, 2026 reported Aug 4, 2026 Operating margin 35% Net profit $0.34B	Apr 1 – Jun 30, 2026	Aug 4, 2026	$1.22B	+10%	35%	$0.34B	28%
Q1 FY26 Jan 1 – Mar 31, 2026 reported May 5, 2026 Operating margin 32% Net profit $0.28B	Jan 1 – Mar 31, 2026	May 5, 2026	$1.14B	+14%	32%	$0.28B	24%
Q4 FY25 Oct 1 – Dec 31, 2025 reported Feb 20, 2026 Operating margin 29% Net profit $0.25B	Oct 1 – Dec 31, 2025	Feb 20, 2026	$1.09B	+14%	29%	$0.25B	23%
Q3 FY25 Jul 1 – Sep 30, 2025 reported Nov 3, 2025 Operating margin 32% Net profit $0.28B	Jul 1 – Sep 30, 2025	Nov 3, 2025	$1.11B	+13%	32%	$0.28B	25%
Q2 FY25 Apr 1 – Jun 30, 2025 reported Aug 4, 2025 Operating margin 34% Net profit $0.29B	Apr 1 – Jun 30, 2025	Aug 4, 2025	$1.11B	+11%	34%	$0.29B	26%